BGD — Biogened SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN49.13m
- PLN63.46m
- PLN113.11m
Annual cashflow statement for Biogened SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.96 | 3.38 | 5.1 | 5.82 | 4.94 |
| Depreciation | |||||
| Non-Cash Items | -0.578 | 1.8 | 2.42 | 2.53 | 1.73 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.12 | -2.11 | 3.84 | -8.49 | 1.43 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 3.14 | 6.01 | 14.9 | 4 | 12.5 |
| Capital Expenditures | -1.57 | -9.36 | -7.15 | -5.49 | -7.35 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.487 | — | — | — | 0.421 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -1.08 | -9.36 | -7.15 | -5.49 | -6.93 |
| Financing Cash Flow Items | 0.827 | 2.01 | 0.98 | -1.35 | -0.951 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.357 | 1.84 | -3.66 | 0.05 | -5.29 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.42 | -1.51 | 4.06 | -1.44 | 0.254 |